Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
6
×
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
generic drugs
6
×
indiana blog main
indiana top stories
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
6
×
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
deals
drug prices
startups
cancer
fda
medicare
cancer immunotherapy
clinical trials
eli lilly
gene therapy
glaxosmithkline
novartis
What
bio
roundup
drugs
drug
new
pharmaceutical
acquisitions
afternoon
ahead
albert
anticipated
appetite
approval
asco
awaited
bails
biggest
biogen’s
biopharmaceutical
black
blueprint
bourla
brand
branded
bread
bridgebio
butter
buyout
cancer
capital
car
cash
ceo
choices
commissioner
companies
company
consumers
convo
cost
Language
unknown
unset
Current search:
biotech
×
" generic drugs "
×
" raleigh-durham blog main "
×
@xconomy.com
4 years ago
Bio Roundup: Ichnos Emerges, Beyond CAR-T, BridgeBio Bails & More
@xconomy.com
4 years ago
Bio Roundup: Pfizer’s Future, CRISPR in Patients, Drug Imports & More
@xconomy.com
5 years ago
Bio Roundup: Generic Drugs Graft, ASCO Ahead, ElevateBio Rises & More
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
@xconomy.com
5 years ago
Bio Roundup: #JPM19 Notes, Loxo Buyout, Black Diamond’s Cash & More
@xconomy.com
6 years ago
Trump Pledges Lower Drug Prices, But Blueprint Is Short on Details